First Time Loading...

Genenta Science SPA
NASDAQ:GNTA

Watchlist Manager
Genenta Science SPA Logo
Genenta Science SPA
NASDAQ:GNTA
Watchlist
Price: 3 USD -12.59% Market Closed
Updated: Apr 18, 2024

Intrinsic Value

GNTA's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Genenta Science SpA engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. [ Read More ]

The intrinsic value of one GNTA stock under the Base Case scenario is 1.1 USD. Compared to the current market price of 3 USD, Genenta Science SPA is Overvalued by 63%.

Key Points:
GNTA Intrinsic Value
Base Case
1.1 USD
Overvaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genenta Science SPA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GNTA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Genenta Science SPA

Provide an overview of the primary business activities
of Genenta Science SPA.

What unique competitive advantages
does Genenta Science SPA hold over its rivals?

What risks and challenges
does Genenta Science SPA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genenta Science SPA.

Provide P/S
for Genenta Science SPA.

Provide P/E
for Genenta Science SPA.

Provide P/OCF
for Genenta Science SPA.

Provide P/FCFE
for Genenta Science SPA.

Provide P/B
for Genenta Science SPA.

Provide EV/S
for Genenta Science SPA.

Provide EV/GP
for Genenta Science SPA.

Provide EV/EBITDA
for Genenta Science SPA.

Provide EV/EBIT
for Genenta Science SPA.

Provide EV/OCF
for Genenta Science SPA.

Provide EV/FCFF
for Genenta Science SPA.

Provide EV/IC
for Genenta Science SPA.

Show me price targets
for Genenta Science SPA made by professional analysts.

What are the Revenue projections
for Genenta Science SPA?

How accurate were the past Revenue estimates
for Genenta Science SPA?

What are the Net Income projections
for Genenta Science SPA?

How accurate were the past Net Income estimates
for Genenta Science SPA?

What are the EPS projections
for Genenta Science SPA?

How accurate were the past EPS estimates
for Genenta Science SPA?

What are the EBIT projections
for Genenta Science SPA?

How accurate were the past EBIT estimates
for Genenta Science SPA?

Compare the revenue forecasts
for Genenta Science SPA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genenta Science SPA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genenta Science SPA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genenta Science SPA compared to its peers.

Compare the P/E ratios
of Genenta Science SPA against its peers.

Discuss the investment returns and shareholder value creation
comparing Genenta Science SPA with its peers.

Analyze the financial leverage
of Genenta Science SPA compared to its main competitors.

Show all profitability ratios
for Genenta Science SPA.

Provide ROE
for Genenta Science SPA.

Provide ROA
for Genenta Science SPA.

Provide ROIC
for Genenta Science SPA.

Provide ROCE
for Genenta Science SPA.

Provide Gross Margin
for Genenta Science SPA.

Provide Operating Margin
for Genenta Science SPA.

Provide Net Margin
for Genenta Science SPA.

Provide FCF Margin
for Genenta Science SPA.

Show all solvency ratios
for Genenta Science SPA.

Provide D/E Ratio
for Genenta Science SPA.

Provide D/A Ratio
for Genenta Science SPA.

Provide Interest Coverage Ratio
for Genenta Science SPA.

Provide Altman Z-Score Ratio
for Genenta Science SPA.

Provide Quick Ratio
for Genenta Science SPA.

Provide Current Ratio
for Genenta Science SPA.

Provide Cash Ratio
for Genenta Science SPA.

What is the historical Revenue growth
over the last 5 years for Genenta Science SPA?

What is the historical Net Income growth
over the last 5 years for Genenta Science SPA?

What is the current Free Cash Flow
of Genenta Science SPA?

Financials

Balance Sheet Decomposition
Genenta Science SPA

Current Assets 21.3m
Cash & Short-Term Investments 18.8m
Receivables 2m
Other Current Assets 442.8k
Non-Current Assets 1.1m
PP&E 83k
Other Non-Current Assets 1m
Current Liabilities 1.7m
Accounts Payable 295k
Accrued Liabilities 1m
Other Current Liabilities 426k
Non-Current Liabilities 179.3k
Other Non-Current Liabilities 179.3k
Efficiency

Earnings Waterfall
Genenta Science SPA

Revenue
0 EUR
Operating Expenses
-11.7m EUR
Operating Income
-11.7m EUR
Other Expenses
87.5k EUR
Net Income
-11.6m EUR

Free Cash Flow Analysis
Genenta Science SPA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GNTA Profitability Score
Profitability Due Diligence

Genenta Science SPA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Genenta Science SPA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

GNTA Solvency Score
Solvency Due Diligence

Genenta Science SPA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Genenta Science SPA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GNTA Price Targets Summary
Genenta Science SPA

Wall Street analysts forecast GNTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNTA is 23.46 USD with a low forecast of 21.21 USD and a high forecast of 26.25 USD.

Lowest
Price Target
21.21 USD
607% Upside
Average
Price Target
23.46 USD
682% Upside
Highest
Price Target
26.25 USD
775% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GNTA Price
Genenta Science SPA

1M 1M
-27%
6M 6M
-41%
1Y 1Y
-55%
3Y 3Y
-73%
5Y 5Y
-73%
10Y 10Y
-73%
Annual Price Range
3
52w Low
3
52w High
6.67
Price Metrics
Average Annual Return -24.81%
Standard Deviation of Annual Returns 37.65%
Max Drawdown -75%
Shares Statistics
Market Capitalization 54.7m USD
Shares Outstanding 18 217 000
Percentage of Shares Shorted 0.03%

GNTA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Genenta Science SPA Logo
Genenta Science SPA

Country

Italy

Industry

Biotechnology

Market Cap

54.7m USD

Dividend Yield

0%

Description

Genenta Science SpA engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. The company is headquartered in Milan, Milano and currently employs 4 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.

Contact

MILANO
Milan
Via Olgettina 58
http://www.genenta.com/

IPO

2021-12-15

Employees

4

Officers

Vice Chairman of the Board, CEO & GM
Mr. Pierluigi Paracchi
Co-Founder & Chairman of the Executive Scientific Board
Dr. Luigi Naldini M.D., Ph.D.
Co-Founder & Member of the Executive Scientific Board
Dr. Bernard Rudolph Gentner M.D., Ph.D.
Chief Financial Officer
Mr. Richard B. Slansky
Chief Medical Officer & Head of Development
Dr. Carlo Russo M.D.
Director of Program Development
Dr. Stefania Mazzoleni Ph.D.
Show More
Director of Finance
Ms. Barbara Regonini
Show Less

See Also

Discover More
What is the Intrinsic Value of one GNTA stock?

The intrinsic value of one GNTA stock under the Base Case scenario is 1.1 USD.

Is GNTA stock undervalued or overvalued?

Compared to the current market price of 3 USD, Genenta Science SPA is Overvalued by 63%.